|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.98 CNY | +2.80% |
|
+6.66% | -11.35% |
| Jul. 16 | FDA Grants Orphan Drug Designation to 7MW3711 | CI |
| Jul. 15 | Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC | CI |
Mabwell (Shanghai) Bioscience Co., Ltd. has been added to Shanghai Stock Exchange Composite Index.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.35% | 1.59B | |
| +20.03% | 126B | |
| +23.61% | 117B | |
| +22.53% | 27.52B | |
| -18.07% | 20.87B | |
| -14.13% | 17.01B | |
| -14.81% | 16.26B | |
| +9.78% | 14.56B | |
| -46.10% | 15.09B | |
| +52.34% | 13.89B |
MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. 